Recombinant Mouse UPF0575 protein C19orf67 homolog is a protein encoded in mice by the gene C19orf67 . Orthologs of C19orf67 are found in mammals, reptiles, and jawed fish . In humans, UPF0575 protein C19orf67 is highly expressed in the testis and breast tissue, but it is also expressed at low levels in the stomach, cerebral cortex, thyroid gland, and salivary gland .
In humans, the C19orf67 gene is located on the minus strand of Chromosome 19 at 19p13.12 and spans 4,163 base pairs (bp) . The following genes are found near C19orf67 on the positive strand: MISP3, Eukaryotic Translation Elongation Factor 1 Delta Pseudogene 1 (EEF1DP1), and MicroRNA 1199 (MIR1199) .
C19orf67 has three transcript variants, but only the first two are protein-coding transcripts . The first transcript consists of 1447bp, while the second and third have 751bp and 656bp, respectively . The mature mRNA of the longest isoform is made up of 6 exons . It is suspected that the mature mRNA of C19orf67 forms a stem loop on the 3' UTR that spans from 1,296bp to 1,350bp of the transcript .
Both isoforms contain DUF3314, and the first isoform has a non-repeating proline-rich region from amino acids 12 to 80 . A cross-program consensus predicted that UPF0575 protein C19orf67 forms four alpha helices and two beta sheets in the locations in the amino acid sequence detailed in the table below :
| Helix | 52-62 |
| 90-108 | |
| 115-125 | |
| 153-180 | |
| Sheet | 193-202 |
| 210-217 |
Acetylation is likely to occur at the N-terminus, while the C-terminus is unlikely to be modified . O-Glycosylation is predicted to occur at amino acids 18 and 67 . Several possible phosphorylation sites were identified along with the associated kinases as shown in the table below :
| Location | Amino acid | Kinase |
|---|---|---|
| 67 | Serine | cdk5 |
| 127 | Threonine | PKC |
| 169 | Threonine | PKC |
| 196 | Serine | cdc2 |
| 204 | Serine | PKA |
| 299 | Tyrosine | SRC |
| 346 | Serine | PKA/PKG |
UPF0575 protein C19orf67 is expected to be targeted in the nucleus, specifically the nucleolus .
The promoter region is predicted to start 1,303 bp upstream from the 5' UTR and consist of 1,447 bp, causing 144 bp to overlap with the 5' UTR . A number of transcription factors such as FOXP1, SOX5, SOX6, SOX4, and MZF1 are likely to bind with the promoter, often acting to downregulate transcription .
There are no known paralogs of UPF0575 protein C19orf67, nor are there any known paralogous domains of DUF3314 found . Orthologs of UPF0575 protein C19orf67 were found to be present among a wide variety of mammals with it being particularly well represented in rodentia and primates . Orthologs were also found in each reptilian order but were much more scarce in presence relative to mammals . A high number and variety of ray-finned fishes were found to have orthologs, while there were fewer cartilaginous fish found to have orthologs; no jawless fish could be found with orthologs . No orthologs are known to be present in birds or amphibians . No invertebrates, fungi, bacteria, or lower species have known orthologs .
UPF0575 protein C19orf67 consists of one family, and there are no apparent duplications throughout the evolution of UPF0575 protein C19orf67 . The DUF3314 region of the gene appears to have diverged at a slower rate relative to the rest of the gene, indicating that that region may have been undergoing purifying selection because that region played an important role in the protein .
UPF0575 protein C19orf67 homolog is a protein encoded by the 1700067K01Rik gene in Mus musculus (house mouse) . It is the murine ortholog of the human C19orf67 gene product. The "UPF" designation indicates it belongs to an uncharacterized protein family, suggesting its function has not been fully elucidated. The protein contains the evolutionarily conserved DUF3314 domain that is predicted to form numerous alpha helices, potentially essential to its function . Based on homology studies, this protein is conserved across mammals and is found in some reptiles and most jawed fish, indicating potential evolutionary importance .
While specific mouse protein data is limited in the search results, we can extrapolate from human ortholog data that the mouse protein likely shares similar characteristics. The human ortholog contains 358 amino acids with a predicted molecular weight of approximately 40kDa, a charge of -11, and an isoelectric point of 5 . A notable feature is its high proline content (12.3%), which exceeds that of 95% of comparable human proteins . The protein contains the highly conserved DUF3314 region which is predicted to form numerous alpha helices . Recombinant versions of this protein are typically produced in E. coli expression systems .
Based on information from the human ortholog, we can infer that the mouse UPF0575 protein C19orf67 homolog is likely expressed at low levels throughout the body with potentially higher expression in specific tissues such as testis and breast tissue (as observed in humans) . Researchers should conduct tissue-specific expression analyses in mice to confirm these patterns, potentially using techniques such as qRT-PCR, RNA-seq, or immunohistochemistry with specific antibodies against the mouse protein to determine its precise expression pattern across different tissues and developmental stages.
To elucidate the function of this relatively understudied protein, researchers should consider a multi-faceted approach:
Protein interaction studies: Employ techniques such as co-immunoprecipitation, yeast two-hybrid screening, or proximity labeling methods (BioID or APEX) to identify protein interaction partners.
Subcellular localization experiments: Based on the prediction that the human ortholog localizes to the nucleus , researchers should verify the subcellular localization in mouse cells using fluorescently tagged versions of the protein or immunocytochemistry with specific antibodies.
Gene knockout or knockdown studies: Generate knockout mice using CRISPR-Cas9 or employ siRNA/shRNA approaches in cell culture to observe phenotypic changes.
Proteomic analyses: Utilize mass spectrometry-based approaches to identify post-translational modifications that might regulate protein function.
Transcriptomic analyses: Conduct RNA-seq after manipulation of protein expression to identify downstream effectors or regulatory pathways.
These methodologies should be combined with careful phenotypic characterization to correlate molecular changes with physiological effects.
The DUF3314 domain is highly conserved and predicted to form numerous alpha helices, suggesting functional importance . To investigate its role:
Structure-function analysis: Create a series of deletion mutants or point mutations within the DUF3314 domain and assess their effects on protein function, localization, and interaction partners.
Domain swapping experiments: Replace the DUF3314 domain with homologous domains from other species to assess functional conservation.
Structural studies: Express and purify the DUF3314 domain for X-ray crystallography, NMR spectroscopy, or cryo-EM analysis to determine its three-dimensional structure.
Molecular dynamics simulations: Use computational approaches to predict conformational changes of the domain under different conditions.
Evolutionary analysis: Compare the DUF3314 sequences across species to identify highly conserved residues that may be essential for function.
Each approach should be followed by functional validation to connect structural features with biological activity.
The choice should be guided by the intended experimental use, required protein purity, and whether post-translational modifications are essential for the protein's function.
While specific purification protocols for this protein are not detailed in the search results, effective strategies can be designed based on general protein characteristics:
Affinity chromatography: Use of histidine tags (as seen in commercial products ) enables purification via nickel or cobalt affinity columns. Based on available recombinant products, a C-terminal His tag approach may be effective .
Ion exchange chromatography: Given the predicted isoelectric point of 5 (based on human ortholog data ), cation exchange chromatography at pH below 5 or anion exchange above pH 5 could be effective.
Size exclusion chromatography: As a polishing step to separate the target protein from aggregates or degradation products.
Optimization considerations:
Buffer conditions: Test various pH values and salt concentrations to maximize protein stability and solubility
Protease inhibitors: Include during extraction and initial purification steps
Reducing agents: Consider including DTT or β-mercaptoethanol if the protein contains cysteine residues
Temperature: Perform purification at 4°C to minimize degradation
A typical purification workflow might include initial capture by affinity chromatography, followed by ion exchange and size exclusion as polishing steps.
UPF0575 protein C19orf67 homolog shows significant evolutionary conservation. Orthologs have been identified in many mammals, some reptiles, and most jawed fish . This broad conservation suggests an important biological function that has been maintained throughout vertebrate evolution.
The protein contains a highly conserved DUF3314 domain that appears to be critical to its function . The conservation pattern of this domain can provide clues about functionally important residues or regions within the protein.
Conservation data across selected species:
Researchers can use phylogenetic analyses and sequence alignments to identify highly conserved motifs or residues within the protein, which often correspond to functionally critical regions. Molecular evolution studies, such as dN/dS ratio analysis, can also reveal whether certain regions of the protein are under purifying or positive selection, providing additional insights into functional constraints.
Based on the search results, multiple isoforms of UPF0575 protein C19orf67 homolog have been identified in various species. For example, in Papio anubis (olive baboon), at least two isoforms (X1 and X2) have been documented . The human ortholog appears to have three transcript variants, although only two are protein-coding .
For comprehensive isoform analysis, researchers should:
Conduct detailed RNA-seq analyses across different tissues and developmental stages to identify all potential mouse isoforms
Perform comparative analyses of isoform expression patterns across species
Investigate whether different isoforms have distinct subcellular localizations or interaction partners
Determine if isoform ratios change under different physiological or pathological conditions
Understanding isoform diversity can provide insights into potential tissue-specific or context-dependent functions of this protein family.
While specific regulatory mechanisms for mouse UPF0575 protein C19orf67 homolog are not detailed in the search results, researchers interested in understanding its regulation should investigate:
Transcriptional regulation: Analyze the promoter region to identify potential transcription factor binding sites. Conduct chromatin immunoprecipitation (ChIP) experiments to confirm these interactions.
Epigenetic regulation: Examine DNA methylation patterns and histone modifications in the gene's regulatory regions across different tissues or developmental stages.
Post-transcriptional regulation: Investigate potential microRNA binding sites in the mRNA that might regulate translation efficiency or mRNA stability.
Post-translational modifications: Identify potential phosphorylation, ubiquitination, or other modification sites that might regulate protein stability or activity.
Signaling pathways: Determine if expression changes in response to specific signaling pathways or cellular stresses.
Experiments should include reporter assays with the gene's promoter, RNA stability assessments, and protein half-life determinations to comprehensively understand its regulation.
To accurately measure expression levels of mouse UPF0575 protein C19orf67 homolog:
mRNA quantification:
qRT-PCR: Design specific primers spanning exon-exon junctions to avoid genomic DNA amplification
RNA-seq: For genome-wide expression analysis and detection of potential novel isoforms
Northern blotting: For visualization of transcript size and abundance
Protein quantification:
Western blotting: Using specific antibodies against the mouse protein
ELISA: For quantitative measurement in tissue lysates or biological fluids
Mass spectrometry: For absolute quantification and identification of post-translational modifications
Spatial expression:
In situ hybridization: To visualize mRNA distribution in tissues
Immunohistochemistry: To detect protein localization in tissue sections
Single-cell RNA-seq: To analyze expression heterogeneity within tissues
Experimental considerations:
Include appropriate housekeeping genes or proteins as internal controls
Validate antibody specificity using knockout or knockdown controls
Consider temporal dynamics of expression when designing experiments
These methodologies should be selected based on the specific research question, required sensitivity, and available resources.
Since UPF0575 protein C19orf67 homolog is relatively understudied, specific phenotypes associated with its altered expression are not well documented in the search results. Researchers investigating phenotypic effects should:
Generate knockout or knockdown models (whole organism or tissue-specific) using CRISPR-Cas9 or RNA interference technologies.
Create overexpression models to assess gain-of-function effects.
Conduct comprehensive phenotypic analyses including:
Developmental assessments: Embryonic viability, growth patterns, organ development
Histological examinations: Tissue architecture and cellular morphology
Behavioral studies: For potential neurological phenotypes
Reproductive assessments: Given potential testis expression based on human data
Molecular profiling: Transcriptomics and proteomics to identify affected pathways
Investigate cell-autonomous effects in primary cells isolated from modified animals or in cell lines with manipulated expression.
These approaches should be complemented with rescue experiments to confirm the specificity of observed phenotypes.
To elucidate the interaction network and pathway involvement of mouse UPF0575 protein C19orf67 homolog:
Protein interaction mapping:
Immunoprecipitation followed by mass spectrometry (IP-MS)
Yeast two-hybrid screening
Proximity-dependent biotin identification (BioID)
Cross-linking mass spectrometry to capture transient interactions
Pathway analysis:
Phosphoproteomic analysis after protein depletion to identify affected signaling pathways
Transcriptomic profiling to identify genes whose expression changes upon protein manipulation
Genetic interaction screens to identify synthetic lethal or synthetic viable interactions
Co-localization studies:
Fluorescence co-localization with potential interacting partners
FRET or BRET analyses to confirm direct interactions in living cells
Functional validation:
Mutagenesis of key residues to disrupt specific interactions
Domain deletion analysis to map interaction interfaces
Competitive peptide inhibition to confirm specificity of interactions
These approaches should be integrated to build a comprehensive understanding of how this protein functions within broader cellular networks.